TI  - Reply to Letter to the Editor: “Critical Appraisal  of Isorhamnetin as a Candidate for Pulmonary  Arterial Hypertension Treatment”
AU  - Liu, Y.
SO  - The Anatolian Journal of Cardiology 2025;29:376-376.
DO  - 10.14744/AnatolJCardiol.2025.5304